Association between serum PAGln,SCFAs levels and ventricular remodeling and prognosis in patients with chronic heart failure
10.3969/j.issn.1673-4130.2025.13.005
- VernacularTitle:血清PAGln、SCFAs水平与慢性心力衰竭患者心室重塑及预后的关系
- Author:
Yongchao ZHANG
1
;
Chunlan LIN
;
Kuan LIANG
;
Wenbin ZHANG
Author Information
1. 重庆市九龙坡区人民医院心血管内科,重庆 400050
- Keywords:
chronic heart failure;
phenylacetylglutamine;
short-chain fatty acids;
ventricular remod-eling;
prognosis
- From:
International Journal of Laboratory Medicine
2025;46(13):1561-1567
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relationship between serum phenylacetylglutamine(PAGln),short-chain fatty acids(SCFAs)levels and ventricular remodeling and prognosis in patients with chronic heart failure(CHF).Methods A total of 267 CHF patients treated at Jiulongpo District People's Hospital of Chongqing from January 2019 to December 2022 were selected as the CHF group,and 100 healthy individuals underwent physical examination during the same period were selected as the control group.CHF patients were further divided into a poor prognosis group(n=63)and a good prognosis group(n=204)based on 1-year outcomes.Serum levels of PAGln and SCFAs(acetic acid,propionic acid,butyric acid)were measured using liquid chromatography-tandem mass spectrometry.Echocardiography was used to assess ventricular remode-ling indicators including left ventricular mass index(LVMI),interventricular septal thickness in diastole(IVST),left ventricular posterior wall thickness(LVPWT),and left ventricular end-diastolic diameter(LVEDD).Pearson correlation was used to analyze the associations between serum PAGln,SCFAs levels and LVMI,IVST,LVPWT,LVEDD.Multivariate logistic regression was used to identify risk factors for poor prognosis in CHF patients,and receiver operating characteristic(ROC)curves were used to assess the predic-tive value of PAGln and SCFAs levels.Results Serum PAGln levels were significantly higher in the CHF group than in the control group,while acetic acid,propionic acid,and butyric acid levels were significantly low-er(P＜0.05).LVMI,IVST,LVPWT,and LVEDD were significantly elevated in the CHF group compared to the control group(P＜0.05).Serum PAGln levels were positively correlated with LVMI,IVST,LVPWT,and LVEDD(P＜0.05),while SCFAs levels were negatively correlated with these parameters(P＜0.05).Univa-riate analysis showed that age,duration of CHF,NYHA functional classification,atrial fibrillation,LVEF,NT-proBNP,PAGln,acetic acid,propionic acid,and butyric acid were associated with poor prognosis(P＜0.05).Multivariate analysis identified NYHA class Ⅲ-Ⅳ,atrial fibrillation,elevated NT-proBNP,and elevated PA-Gln as independent risk factors for poor prognosis,while higher LVEF and increased levels of acetic acid,pro-pionic acid,and butyric acid were independent protective factors(P＜0.05).ROC curve analysis showed that the area under the curve(AUC)for the combined prediction using PAGln and SCFAs was 0.881,which was greater than that for PAGln(0.800)or SCFAs(0.789)alone(P＜0.05).Conclusion Elevated serum PAGln and decreased SCFAs levels are closely associated with ventricular remodeling and poor prognosis in CHF pa-tients.The combination of serum PAGln and SCFAs levels has a high predictive value for poor prognosis in CHF.
